Recalled Aprepitant Capsules 125 mg – NDC 0781-2323-68 – Carton
Check the label first
Compare every letter, number, space and suffix. A similar-looking product with a different suffix may not be part of this recall.
Why it was recalled
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
None reported
The official remedy
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Product and sales details
How to reach the firm
Verify phone numbers, hours and web addresses on the current CPSC notice before contacting the firm.